On the motion of a classical charged particle

We show that the Lorentz-Dirac equation is not an unavoidable consequence of energy-momentum conservation for a point charge. What follows solely from conservation laws is a less restrictive equation already obtained by Honig and Szamosi. The latter is not properly an equation of motion because, as it contains an extra scalar variable, it does not determine the future evolution of the charge. We show that a supplementary constitutive relation can be added so that the motion is determined and free from the troubles that are customary in Lorentz-Dirac equation, i. e. preacceleration and runaways

Post COP26: does the 1.5°C climate target remain alive?

One of the COP26 aims was to keep 1.5°C within reach by asking countries to come forward with ambitious year 2030 emission reductions targets to further pursue the necessary action to meet the Paris climate targets. We assess the mean global temperature rise given the updated year 2030 emission pledges in the context of future emission pathways considered by the international scientific community. Overall, we find current pledges are not consistent with a likely meeting of 1.5°C this century without overshoot. Meeting the 1.5°C goal in 2100 post overshoot given the pledges remains feasible, but urgent action is required to ensure pledges are met and policies are in place for the very deep and rapid emission reductions that are required post 2030

30 Years of Progress toward Increased Biomass Yield of Switchgrass and Big Bluestem

Breeding to improve biomass production of switchgrass (Panicum virgatum L.) and big bluestem (Andropogon gerardii Vitman) for conversion to bioenergy began in 1992. The purpose of this study was (i) to develop a platform for uniform regional testing of cultivars and experimental populations for these species, and (ii) to estimate the gains made by breeding during 1992 to 2012. A total of 25 switchgrass populations and 16 big bluestem populations were planted in uniform regional trials at 13 locations in 2012 and 2014. The reference region was USDA Hardiness Zones 3 through 6 in the humid temperate United States. Significant progress toward increased biomass yield was made in big bluestem and within upland-ecotype populations, lowland-ecotype populations, and hybrid-derived populations of switchgrass. Four mechanisms of increasing biomass yield were documented: (i) increased biomass yield per se, (ii) later flowering to extend the growing season, (iii) combined later flowering from the lowland ecotype with survivorship of the upland ecotype in hybrid-derived populations, and (iv) increased survivorship of late-flowering lowland populations in hardiness zones that represent an expansion of their natural adaption zone. Switchgrass exhibited all four mechanisms in one or more improved populations, whereas improved populations of big bluestem were likely influenced by two of the four mechanisms. The uniform testing program was successful at documenting increases in biomass yield, identifying the mechanisms for increased yield, and determining adaptation characteristics and limitations of improved populations

30 Years of Progress toward Increased Biomass Yield of Switchgrass and Big Bluestem

Breeding to improve biomass production of switchgrass (Panicum virgatum L.) and big bluestem (Andropogon gerardii Vitman) for conversion to bioenergy began in 1992. The purpose of this study was (i) to develop a platform for uniform regional testing of cultivars and experimental populations for these species, and (ii) to estimate the gains made by breeding during 1992 to 2012. A total of 25 switchgrass populations and 16 big bluestem populations were planted in uniform regional trials at 13 locations in 2012 and 2014. The reference region was USDA Hardiness Zones 3 through 6 in the humid temperate United States. Significant progress toward increased biomass yield was made in big bluestem and within upland-ecotype populations, lowland-ecotype populations, and hybrid-derived populations of switchgrass. Four mechanisms of increasing biomass yield were documented: (i) increased biomass yield per se, (ii) later flowering to extend the growing season, (iii) combined later flowering from the lowland ecotype with survivorship of the upland ecotype in hybrid-derived populations, and (iv) increased survivorship of late-flowering lowland populations in hardiness zones that represent an expansion of their natural adaption zone. Switchgrass exhibited all four mechanisms in one or more improved populations, whereas improved populations of big bluestem were likely influenced by two of the four mechanisms. The uniform testing program was successful at documenting increases in biomass yield, identifying the mechanisms for increased yield, and determining adaptation characteristics and limitations of improved populations

Hydrogen Epoch of Reionization Array (HERA)

The Hydrogen Epoch of Reionization Array (HERA) is a staged experiment to measure 21 cm emission from the primordial intergalactic medium (IGM) throughout cosmic reionization ($z=6-12$), and to explore earlier epochs of our Cosmic Dawn ($z\sim30$). During these epochs, early stars and black holes heated and ionized the IGM, introducing fluctuations in 21 cm emission. HERA is designed to characterize the evolution of the 21 cm power spectrum to constrain the timing and morphology of reionization, the properties of the first galaxies, the evolution of large-scale structure, and the early sources of heating. The full HERA instrument will be a 350-element interferometer in South Africa consisting of 14-m parabolic dishes observing from 50 to 250 MHz. Currently, 19 dishes have been deployed on site and the next 18 are under construction. HERA has been designated as an SKA Precursor instrument. In this paper, we summarize HERA's scientific context and provide forecasts for its key science results. After reviewing the current state of the art in foreground mitigation, we use the delay-spectrum technique to motivate high-level performance requirements for the HERA instrument. Next, we present the HERA instrument design, along with the subsystem specifications that ensure that HERA meets its performance requirements. Finally, we summarize the schedule and status of the project. We conclude by suggesting that, given the realities of foreground contamination, current-generation 21 cm instruments are approaching their sensitivity limits. HERA is designed to bring both the sensitivity and the precision to deliver its primary science on the basis of proven foreground filtering techniques, while developing new subtraction techniques to unlock new capabilities. The result will be a major step toward realizing the widely recognized scientific potential of 21 cm cosmology.Comment: 26 pages, 24 figures, 2 table

What is evidence required for and who generates that evidence in the Finnish Educational System?

Peer reviewe

Divergent responses to peptidoglycans derived from different E. coli serotypes influence inflammatory outcome in trout, Oncorhynchus mykiss, macrophages

Background: Pathogen-associated molecular patterns (PAMPs) are structural components of pathogens such as lipopolysaccharide (LPS) and peptidoglycan (PGN) from bacterial cell walls. PAMP-recognition by the host results in an induction of defence-related genes and often the generation of an inflammatory response. We evaluated both the transcriptomic and inflammatory response in trout (O. mykiss) macrophages in primary cell culture stimulated with DAP-PGN (DAP; meso-diaminopimelic acid, PGN; peptidoglycan) from two strains of Escherichia coli (PGN-K12 and PGN-O111:B4) over time. Results: Transcript profiling was assessed using function-targeted cDNA microarray hybridisation (n = 36) and results show differential responses to both PGNs that are both time and treatment dependent. Wild type E. coli (K12) generated an increase in transcript number/diversity over time whereas PGN-O111:B4 stimulation resulted in a more specific and intense response. In line with this, Gene Ontology analysis (GO) highlights a specific transcriptomic remodelling for PGN-O111:B4 whereas results obtained for PGN-K12 show a high similarity to a generalised inflammatory priming response where multiple functional classes are related to ribosome biogenesis or cellular metabolism. Prostaglandin release was induced by both PGNs and macrophages were significantly more sensitive to PGN-O111:B4 as suggested from microarray data. Conclusion: Responses at the level of the transcriptome and the inflammatory outcome (prostaglandin synthesis) highlight the different sensitivity of the macrophage to slight differences (serotype) in peptidoglycan structure. Such divergent responses are likely to involve differential receptor sensitivity to ligands or indeed different receptor types. Such changes in biological response will likely reflect upon pathogenicity of certain serotypes and the development of disease

Embracing open innovation to acquire external ideas and technologies and to transfer internal ideas and technologies outside

The objective of this dissertation is to increase understanding of how organizations can embrace open innovation in order to acquire external ideas and technologies from outside the organization, and to transfer internal ideas and technologies to outside the organization. The objective encompasses six sub-objectives, each addressed in one or more substudies. Altogether, the dissertation consists of nine substudies and a compendium summarizing the substudies. An extensive literature review was conducted on open innovation and crowdsourcing literature (substudies 1–4). In the subsequent empirical substudies, both qualitative research methods (substudies 5–7) and quantitative research methods (substudies 8–9) were applied. The four literature review substudies provided insights on the body of knowledge on open innovation and crowdsourcing. These substudies unveiled most of the influential articles, authors, and journals of open innovation and crowdsourcing disciplines. Moreover, they identified research gaps in the current literature. The empirical substudies offer several insightful findings. Substudy 5 shows how non-core ideas and technologies of a large firm can become valuable, especially for small firms. Intermediary platforms can find solutions to many pressing problems of large organizations by engaging renowned scientists from all over world (substudy 6). Intermediary platforms can also bring breakthrough innovations with novel mechanisms (substudy 7). Large firms are not only able to garner ideas by engaging their customers through crowdsourcing but they can also build long-lasting relations with their customers (substudies 8 and 9). Embracing open innovation brings challenges for firms too. Firms need to change their organizational structures in order to be able to fully benefit from open innovation. When crowdsourcing is successful, it produces a very large number of new ideas. This has the consequence that firms need to allocate a significant amount of resources in order to identify the most promising ideas. In an idea contest, customarily, only one or a few best ideas are rewarded (substudy 7). Sometimes, no reward is provided for the selected idea (substudies 8 and 9). Most of the ideas that are received are not implemented in practice

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness

Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually. The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., respectively. These parasites have similar biology and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target. However, no such molecular targets or broad spectrum drugs have been identified to date. Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection. GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice. Our data provide genetic and chemical validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases